{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T20:06:49Z","timestamp":1784837209148,"version":"3.55.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1097\/aln.0b013e31829ff30f","type":"journal-article","created":{"date-parts":[[2013,8,21]],"date-time":"2013-08-21T05:27:31Z","timestamp":1377062851000},"page":"735-736","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Hydroxyethyl Starch 130\/0.4: Safe for the Kidney in Surgical Patients?"],"prefix":"10.1097","volume":"119","author":[{"given":"Christian J.","family":"Wiedermann","sequence":"first","affiliation":[{"name":"Central Hospital of Bolzano, Bolzano, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20241223","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00508-004-0237-3","article-title":"Hydroxyethyl starch\u2014Can the safety problems be ignored?","volume":"116","year":"2004","journal-title":"Wien Klin Wochenschr"},{"key":"R2-20241223","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/jama.2013.430","article-title":"Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: A systematic review and meta-analysis.","volume":"309","year":"2013","journal-title":"JAMA"},{"key":"R3-20241223","first-page":"CD000567","article-title":"Colloids versus crystalloids for fluid resuscitation in critically ill patients.","volume":"2","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R4-20241223","first-page":"w13747","article-title":"Increased mortality after infusion of \u201cmodern\u201d hydroxyethyl starch.","volume":"143","year":"2013","journal-title":"Swiss Med Wkly"},{"key":"R5-20241223","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00134-013-2840-0","article-title":"Fluid resuscitation with 6% hydroxyethyl starch (130\/0.4 and 130\/0.42) in acutely ill patients: Systematic review of effects on mortality and treatment with renal replacement therapy.","volume":"39","year":"2013","journal-title":"Intensive Care Med"},{"key":"R6-20241223","doi-asserted-by":"crossref","first-page":"f839","DOI":"10.1136\/bmj.f839","article-title":"Hydroxyethyl starch 130\/0.38-0.45 versus crystalloid or albumin in patients with sepsis: Systematic review with meta-analysis and trial sequential analysis.","volume":"346","year":"2013","journal-title":"BMJ"},{"key":"R7-20241223","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00134-013-2863-6","article-title":"Randomised trials of 6% tetrastarch (hydroxyethyl starch 130\/0.4 or 0.42) for severe sepsis reporting mortality: Systematic review and meta-analysis.","volume":"39","year":"2013","journal-title":"Intensive Care Med"},{"key":"R8-20241223","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJMoa1204242","article-title":"Hydroxyethyl starch 130\/0.4 versus Ringer\u2019s acetate in severe sepsis.","volume":"367","year":"2012","journal-title":"N Engl J Med"},{"key":"R9-20241223","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012.","volume":"41","year":"2013","journal-title":"Crit Care Med"},{"key":"R10-20241223","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/ALN.0b013e31827e5569","article-title":"Effect of waxy maize-derived hydroxyethyl starch 130\/0.4 on renal function in surgical patients.","volume":"118","year":"2013","journal-title":"Anesthesiology"},{"key":"R11-20241223","doi-asserted-by":"crossref","first-page":"149","DOI":"10.7326\/0003-4819-135-3-200108070-00007","article-title":"Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials.","volume":"135","year":"2001","journal-title":"Ann Intern Med"},{"key":"R12-20241223","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(00)04211-2","article-title":"Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: A multicentre randomised study.","volume":"357","year":"2001","journal-title":"Lancet"},{"key":"R13-20241223","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/S0140-6736(96)07588-5","article-title":"Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients.","volume":"348","year":"1996","journal-title":"Lancet"}],"container-title":["Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pubs.asahq.org\/anesthesiology\/article-pdf\/119\/3\/735\/262375\/20130900_0-00050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/anesthesiology.pubs.asahq.org\/article.aspx?volume=119&page=735","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:22:09Z","timestamp":1784834529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/ALN.0b013e31829ff30f"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/aln.0b013e31829ff30f","relation":{},"ISSN":["0003-3022"],"issn-type":[{"value":"0003-3022","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}